{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:23:08Z","timestamp":1761016988408},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T00:00:00Z","timestamp":1343692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2369-13-73","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T14:15:15Z","timestamp":1343744115000},"source":"Crossref","is-referenced-by-count":3,"title":["Sometimes when you hear hoof beats, it could be a zebra: consider the diagnosis of Fabry disease"],"prefix":"10.1186","volume":"13","author":[{"given":"James O","family":"Burton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P","family":"Dormer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen E","family":"Binns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren P","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,31]]},"reference":[{"key":"310_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M: Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004, 34: 236-242. 10.1111\/j.1365-2362.2004.01309.x.","journal-title":"Eur J Clin Invest"},{"issue":"443","key":"310_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1651-2227.2003.tb00212.x","volume":"92","author":"A Sessa","year":"2003","unstructured":"Sessa A, Meroni M, Battini G, Righetti M, Nebuloni M, Tosoni A, Vago GL: Evolution of renal pathology in Fabry disease. Acta paediatrica (Oslo, Norway : 1992) Supplement. 2003, 92 (443): 6-8. discussion 5","journal-title":"Acta paediatrica (Oslo, Norway : 1992) Supplement"},{"key":"310_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10545-010-9261-9","volume":"34","author":"A Gal","year":"2011","unstructured":"Gal A, Hughes DA, Winchester B: Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J Inherit Metab Dis. 2011, 34: 509-514. 10.1007\/s10545-010-9261-9.","journal-title":"J Inherit Metab Dis"},{"key":"310_CR4","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI114027","volume":"83","author":"H Bernstein","year":"1989","unstructured":"Bernstein H, Bishop D, Astrin K, Komreich R, Eng C, Sakuraba H, Desnick R: Fabry disease: six gene rearrangements and an exonic point mutation in the a-galactosidase gene. J Clin Invest. 1989, 83: 1390-1399. 10.1172\/JCI114027.","journal-title":"J Clin Invest"},{"key":"310_CR5","first-page":"784","volume":"47","author":"H Sakuraba","year":"1990","unstructured":"Sakuraba H, Oshima A, Fukuhara Y, Shimmoto M, Nagao Y, Bishop D, Desnick R, Suzuki Y: Identification of point mutations in the a-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet. 1990, 47: 784-789.","journal-title":"Am J Hum Genet"},{"key":"310_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Turkel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ: High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet. 2006, 79: 31-40. 10.1086\/504601.","journal-title":"Am J Hum Genet"},{"key":"310_CR7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtl\u00e4nder T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, et al: Results of a nationwide screening for Anderson\u2013Fabry disease among dialysis patients. J Am Soc Nephrol. 2004, 15: 1323-1329. 10.1097\/01.ASN.0000124671.61963.1E.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"310_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmg.2009.072116","volume":"47","author":"GE Linthorst","year":"2010","unstructured":"Linthorst GE, Bouwman MG, Wijburg FA, Aerts JMFG, Poorthuis BJHM, Hollak CEM: Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet. 2010, 47 (4): 217-222. 10.1136\/jmg.2009.072116.","journal-title":"J Med Genet"},{"key":"310_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"M Branton","year":"2002","unstructured":"Branton M, Schiffmann R, Sabnis S, Murray GJ, Quirk JM, Altarescu G, Brady RO, Goldfarb L, Balow JE, Austin HAI, et al: Natural history of Fabry renal disease: Influence of a-galactosidase activity and genetic mutations on clinical course. Medicine. 2002, 81: 122-138. 10.1097\/00005792-200203000-00003.","journal-title":"Medicine"},{"key":"310_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson\u2013Fabry disease Clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001, 38: 750-760. 10.1136\/jmg.38.11.750.","journal-title":"J Med Genet"},{"key":"310_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson\u2013Fabry disease Clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001, 38: 769-775. 10.1136\/jmg.38.11.769.","journal-title":"J Med Genet"},{"key":"310_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/08035250500275022","volume":"95","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassman G, Widmer U, Beck M: Clinical manifestations of Fabry disease in children: data from the Fabry outcome survey. Acta Paediatr. 2006, 95: 86-92.","journal-title":"Acta Paediatr"},{"issue":"7","key":"310_CR13","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","volume":"25","author":"AB Fogo","year":"2010","unstructured":"Fogo AB, Bostad L, Svarstad E, Cook WJ, Moll S, Barbey F, Geldenhuys L, West M, Ferluga D, Vujkovac B, et al: Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant. 2010, 25 (7): 2168-2177. 10.1093\/ndt\/gfp528.","journal-title":"Nephrol Dial Transplant"},{"key":"310_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ndtplus\/sfm022","volume":"1","author":"F Barbey","year":"2008","unstructured":"Barbey F, Lidove O, Schwarting A: Fabry nephropathy: 5\u2009years of enzyme replacement therapy\u2014a short review. NDT Plus. 2008, 1: 11-19. 10.1093\/ndtplus\/sfm022.","journal-title":"NDT Plus"},{"key":"310_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/PAP.0b013e31803250d8","volume":"14","author":"JM Pullman","year":"2007","unstructured":"Pullman JM, Ferrario F, Nast CC: Actual practices in nephropathology: a survey and comparison with best practices. Adv Anat Pathol. 2007, 14: 132-140. 10.1097\/PAP.0b013e31803250d8.","journal-title":"Adv Anat Pathol"},{"key":"310_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/jcp.53.6.433","volume":"53","author":"PN Furness","year":"2000","unstructured":"Furness PN: ACP. Best practice no 160. Renal biopsy specimens. J Clin Pathol. 2000, 53: 433-438. 10.1136\/jcp.53.6.433.","journal-title":"J Clin Pathol"},{"key":"310_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jcp.49.3.233","volume":"49","author":"PN Furness","year":"1996","unstructured":"Furness PN, Boyd S: Electron microscopy and immunocytochemistry in the assessment of renal biopsy specimens: actual and optimal practice. J Clin Pathol. 1996, 49: 233-237. 10.1136\/jcp.49.3.233.","journal-title":"J Clin Pathol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-73\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-73.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-73","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-73.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T23:49:19Z","timestamp":1714261759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,31]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-73","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,31]]},"article-number":"73"}}